Bio-Techne (TECH) Shares Outstanding (Diluted Average) (2009 - 2021)
Bio-Techne (TECH) recorded quarterly Shares Outstanding (Diluted Average) of $41.2 million in Q4 2021, little changed quarter-over-quarter from $41.2 million in Q3 2021, and up 2.36% on a YoY basis from $40.3 million in Q4 2020.
Bio-Techne (TECH) Shares Outstanding (Diluted Average) (2009 - 2021) Analysis & Trends
Bio-Techne's Shares Outstanding (Diluted Average) history runs 12 years deep, the most recent figure standing at $41.2 million for Q4 2021.
- In Q4 2021, Shares Outstanding (Diluted Average) rose 2.36% year-over-year to $41.2 million; the TTM figure through Dec 2021 stood at $41.2 million (up 2.36% YoY), while the FY2021 annual figure was $40.5 million, up 2.75% from the prior year.
- Shares Outstanding (Diluted Average) was $41.2 million for Q4 2021 at Bio-Techne, roughly flat from $41.2 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $41.2 million in Q4 2021 to a low of $37.5 million in Q1 2017.
- Historically, Shares Outstanding (Diluted Average) has averaged $39.2 million across 5 years, with a median of $39.1 million in 2019.
- The sharpest annual moves came in 2017 and 2021: Shares Outstanding (Diluted Average) climbed 0.47% in 2017, then climbed 3.15% in 2021.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $37.9 million in 2017, then increased by 2.17% to $38.7 million in 2018, then gained by 2.07% to $39.6 million in 2019, then gained by 1.79% to $40.3 million in 2020, then increased by 2.36% to $41.2 million in 2021.
- The last three Shares Outstanding (Diluted Average) figures came in at $41.2 million (Q4 2021), $41.2 million (Q3 2021), and $40.5 million (Q2 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4,489.46 Bn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 810.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 118.76 Bn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Bn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 256.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 92.44 Mn |
| 10 | Bio-Techne | 9.04 Bn | 8.83 Bn | 208.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 41.21 Mn |
| Sep 30, 2021 | 41.16 Mn |
| Jun 30, 2021 | 40.48 Mn |
| Mar 31, 2021 | 40.68 Mn |
| Dec 31, 2020 | 40.26 Mn |
| Sep 30, 2020 | 40.03 Mn |
| Jun 30, 2020 | 39.40 Mn |
| Mar 31, 2020 | 39.44 Mn |
| Dec 31, 2019 | 39.55 Mn |
| Sep 30, 2019 | 39.25 Mn |
| Jun 30, 2019 | 38.89 Mn |
| Mar 31, 2019 | 38.86 Mn |
| Dec 31, 2018 | 38.75 Mn |
| Sep 30, 2018 | 38.81 Mn |
| Jun 30, 2018 | 38.06 Mn |
| Mar 31, 2018 | 38.14 Mn |
| Dec 31, 2017 | 37.93 Mn |
| Sep 30, 2017 | 37.71 Mn |
| Jun 30, 2017 | 37.50 Mn |
| Mar 31, 2017 | 37.49 Mn |